Numerate Overview
- Year Founded
-
2007
- Status
-
Acquired/Merged
- Employees
-
15
- Latest Deal Type
-
M&A
Numerate General Information
Description
Developer of a drug engineering platform designed to transform small molecule drug discovery process. The company's platform combines advances in computer science and statistics with traditional medicinal chemistry to overcome major challenges in small molecule drug discovery and significantly accelerate candidate selection and optimization, enabling pharmaceutical companies to discover new medicines that fills the significant therapeutic gaps by harnessing the vast computational power of the cloud and the ever-increasing amounts of drug discovery data by applying proprietary artificial intelligence algorithms.
Contact Information
Website
www.numerate.comCorporate Office
- 1501 Mariposa Street
- Suite 426
- San Francisco, CA 94107
- United States
Corporate Office
- 1501 Mariposa Street
- Suite 426
- San Francisco, CA 94107
- United States
Numerate Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 8. Merger/Acquisition | 01-Nov-2019 | Completed | Generating Revenue | |||
| 7. Grant | 07-Aug-2019 | Completed | Generating Revenue | |||
| 6. Debt - General | Completed | Generating Revenue | ||||
| 5. Grant | 15-Nov-2017 | Completed | Generating Revenue | |||
| 4. Later Stage VC (Series A) | 04-Jun-2014 | Completed | Generating Revenue | |||
| 3. Early Stage VC (Series B) | 20-Mar-2009 | Completed | Generating Revenue | |||
| 2. Early Stage VC (Series A3) | 17-Nov-2008 | $2.4M | $3.6M | Completed | Generating Revenue | |
| 1. Early Stage VC (Series A2) | 20-May-2008 | $1.2M | $1.2M | Completed | Generating Revenue |
Numerate Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A |
Numerate Comparisons
Industry
Financing
Details
Numerate Competitors (45)
One of Numerate’s 45 competitors is Genesis Molecular AI, a Venture Capital-Backed company based in San Mateo, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Genesis Molecular AI | Venture Capital-Backed | San Mateo, CA | ||||
| X-37 | Venture Capital-Backed | South San Francisco, CA | ||||
| Deep Genomics | Venture Capital-Backed | Toronto, Canada | ||||
| Exscientia | Formerly VC-backed | Oxford, United Kingdom | ||||
| Valo | Venture Capital-Backed | Lexington, MA |
Numerate Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Numerate Patents
Numerate Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2018049328-A1 | Bicyclic compounds useful as gpr120 modulators | Inactive | 12-Sep-2016 | ||
| WO-2018049324-A1 | Monocyclic compounds useful as gpr120 modulators | Inactive | 12-Sep-2016 | ||
| WO-2012078519-A2 | 3-acylidene-2-oxoindole derivatives for inhibition of transglutaminase 2 | Inactive | 06-Dec-2010 | ||
| WO-2012078519-A3 | 3-acylidene-2-oxoindole derivatives for inhibition of transglutaminase 2 | Inactive | 06-Dec-2010 | ||
| CA-2712586-A1 | Antibacterial fluoroquinolone analogs | Inactive | 12-Feb-2008 | C07D471/14 |
Numerate Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Numerate Former Investors (6)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Atlas Venture | Venture Capital | Minority | ||
| Foundation Capital | Venture Capital | Minority | ||
| Lanza techVentures | Venture Capital | Minority | ||
| Lilly Ventures | Corporate Venture Capital | Minority | ||
| National Heart, Lung, and Blood Institute | Government |
Numerate Acquisitions (1)
Numerate’s most recent deal was a Merger/Acquisition with Pharmix. The deal was made on 12-Feb-2008.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Pharmix | 12-Feb-2008 | Merger/Acquisition | Biotechnology |
Numerate FAQs
-
When was Numerate founded?
Numerate was founded in 2007.
-
Where is Numerate headquartered?
Numerate is headquartered in San Francisco, CA.
-
What is the size of Numerate?
Numerate has 15 total employees.
-
What industry is Numerate in?
Numerate’s primary industry is Discovery Tools (Healthcare).
-
Is Numerate a private or public company?
Numerate is a Private company.
-
What is Numerate’s current revenue?
The current revenue for Numerate is .
-
How much funding has Numerate raised over time?
Numerate has raised $18.6M.
-
Who are Numerate’s investors?
Atlas Venture, Foundation Capital, Lanza techVentures, Lilly Ventures, and National Heart, Lung, and Blood Institute are 5 of 6 investors who have invested in Numerate.
-
Who are Numerate’s competitors?
Genesis Molecular AI, X-37, Deep Genomics, Exscientia, and Valo are some of the 45 competitors of Numerate.
-
When was Numerate acquired?
Numerate was acquired on 01-Nov-2019.
-
Who acquired Numerate?
Numerate was acquired by Valo.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
